CUE · Cue Biopharma, Inc.
$34.20
+3.12 (+10.04%)
At close · Aug 14
Going-concern doubt
— cleared Aug 14, 2026
The latest filing no longer states the doubt (first flagged May 14, 2026).
View the 10-Q filed Aug 14, 2026Market Cap
$248.44M
Shares
7.26M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-08-14 | Shao-Lee Lin | Officer, Director | 40,000 | 2026-08-12 | Maxim Group LLC |
| 2026-08-13 | Sumita Ray | Officer, CORPORATE SECRETARY | 8,829 | 2026-08-13 | Maxim Group LLC |
| 2025-12-29 | MATTEO GIACOMO LEVISETTI | Officer | 7,230 | 2025-12-29 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Showing 1–3 of 3 filings